×
Back to Agenda
Compliance: The Importance of Periodic Screenings to Ensure Good Inspection Health
Session Chair(s)
Grace M Crawford, MS
Global Head, Clinical Quality and Compliance, AstraZeneca, United States
The importance of periodic screenings (e.g. assessments, mock inspections) to ensure good inspection health. An interactive and colorful discussion of how being prepared by getting a thorough ‘check-up’ is the best way to be ready for an inspection.
Learning Objective : Demonstrate how periodic screenings are an important part of inspection readiness; Discuss where hidden challenges lurk and how mock inspections can bring these items to light; Identify appropriate remediation plans that are organizationally focused and not study specific.
Speaker(s)
Barbara Maley
President/Managing Member, BLM Quality Consulting, LLC, United States
Panelist
Lauren Blomberg
GCP Inspection Lead, Quality and Continuous Improvement, GCTO, Merck & Co., Inc., United States
Panelist
Gina C Lucas
Director, Strategic Advice, AstraZeneca Pharmaceuticals LP, United States
Panelist
Matthew Krumrai
Director, Clinical Quality Assurance, AbbVie, United States
Panelist
Have an account?